Literature DB >> 24770844

Hypoxic pulmonary vasoconstriction as a contributor to response in acute pulmonary embolism.

K S Burrowes1, A R Clark, M L Wilsher, D G Milne, M H Tawhai.   

Abstract

Hypoxic pulmonary vasoconstriction (HPV) is an adaptive response unique to the lung whereby blood flow is diverted away from areas of low alveolar oxygen to improve ventilation-perfusion matching and resultant gas exchange. Some previous experimental studies have suggested that the HPV response to hypoxia is blunted in acute pulmonary embolism (APE), while others have concluded that HPV contributes to elevated pulmonary blood pressures in APE. To understand these contradictory observations, we have used a structure-based computational model of integrated lung function in 10 subjects to study the impact of HPV on pulmonary hemodynamics and gas exchange in the presence of regional arterial occlusion. The integrated model includes an experimentally-derived model for HPV. Its function is validated against measurements of pulmonary vascular resistance in normal subjects at four levels of inspired oxygen. Our results show that the apparently disparate observations of previous studies can be explained within a single model: the model predicts that HPV increases mean pulmonary artery pressure in APE (by 8.2 ± 7.0% in these subjects), and concurrently shows a reduction in response to hypoxia in the subjects who have high levels of occlusion and therefore maximal HPV in normoxia.

Entities:  

Mesh:

Year:  2014        PMID: 24770844     DOI: 10.1007/s10439-014-1011-y

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  8 in total

1.  Comparison of generic and subject-specific models for simulation of pulmonary perfusion and forced expiration.

Authors:  Kerry L Hedges; Alys R Clark; Merryn H Tawhai
Journal:  Interface Focus       Date:  2015-04-06       Impact factor: 3.906

Review 2.  Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder.

Authors:  Fatemeh Ajalloueian; Greg Lemon; Jöns Hilborn; Ioannis S Chronakis; Magdalena Fossum
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

3.  Analysis of flow resistance in the pulmonary arterial circulation: implications for hypoxic pulmonary vasoconstriction.

Authors:  David W Johnson; Tuhin K Roy; Timothy W Secomb
Journal:  J Appl Physiol (1985)       Date:  2021-08-19

Review 4.  Aerosol Transport Modeling: The Key Link Between Lung Infections of Individuals and Populations.

Authors:  Chantal Darquenne; Azadeh A T Borojeni; Mitchel J Colebank; M Gregory Forest; Balázs G Madas; Merryn Tawhai; Yi Jiang
Journal:  Front Physiol       Date:  2022-06-20       Impact factor: 4.755

5.  Hypoxic pulmonary vasoconstriction as a regulator of alveolar-capillary oxygen flux: A computational model of ventilation-perfusion matching.

Authors:  Andrew D Marquis; Filip Jezek; David J Pinsky; Daniel A Beard
Journal:  PLoS Comput Biol       Date:  2021-05-06       Impact factor: 4.475

6.  Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs.

Authors:  Hiroko Takahama; Hiroshi Asanuma; Osamu Tsukamoto; Shin Ito; Masafumi Kitakaze
Journal:  Int J Cardiol Heart Vasc       Date:  2019-07-10

7.  Effects of prostaglandin E1 nebulization of ventilated lung under 60%O2 one lung ventilation on patients' oxygenation and oxidative stress: a randomised controlled trial.

Authors:  Pengyi Li; Lianbing Gu; Qingming Bian; Jing Tan; Dian Jiao; Fei Wu; Zeping Xu; Lijun Wang
Journal:  Respir Res       Date:  2020-05-13

8.  A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions.

Authors:  Behdad Shaarbaf Ebrahimi; Merryn H Tawhai; Haribalan Kumar; Kelly S Burrowes; Eric A Hoffman; Margaret L Wilsher; David Milne; Alys R Clark
Journal:  Pulm Circ       Date:  2021-11-18       Impact factor: 2.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.